TYKERB for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 10 adverse event reports in the FDA FAERS database where TYKERB was used for Neoplasm malignant.
Most Reported Side Effects for TYKERB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 173 | 32.5% | 3 | 12 |
| Nausea | 63 | 11.8% | 7 | 10 |
| Death | 47 | 8.8% | 47 | 1 |
| Fatigue | 44 | 8.3% | 3 | 5 |
| Drug ineffective | 42 | 7.9% | 1 | 4 |
| Rash | 37 | 6.9% | 0 | 2 |
| Disease progression | 29 | 5.4% | 10 | 3 |
| Vomiting | 29 | 5.4% | 2 | 7 |
| Decreased appetite | 28 | 5.3% | 3 | 2 |
| Palmar-plantar erythrodysaesthesia syndrome | 23 | 4.3% | 0 | 3 |
| Weight decreased | 23 | 4.3% | 2 | 4 |
| Dizziness | 22 | 4.1% | 4 | 8 |
| Dry skin | 22 | 4.1% | 0 | 1 |
| Stomatitis | 19 | 3.6% | 1 | 2 |
| Malaise | 18 | 3.4% | 0 | 0 |
Other Indications for TYKERB
Breast cancer (282)
Product used for unknown indication (133)
Breast cancer metastatic (54)
Breast cancer female (12)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)